Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

Employee Benefits

Cigna PBM expects big savings by adding Humira biosimilars to formulary

December 06, 2022 Reprints

Cigna Corp.’s pharmacy benefit manager Express Scripts on Dec. 5 said it will put multiple biosimilar versions of AbbVie Inc.’s expensive rheumatoid arthritis drug Humira in the “same position as the brand” on the PBM’s formulary in 2023, reports Forbes. Cigna’s decision means potentially thousands of patients could be shifted in 2023 to cheaper alternatives and save Cigna and Express Scripts clients and the U.S. healthcare system potentially billions of dollars a year.

Help

Cigna PBM expects big savings by adding Humira biosimilars to formulary

Readers Poll

Most Read in Employee Benefits

Sign up now for free access to this article and much more.

If you are already registered with Business Insurance, click here to Login

Please tell us a bit more about yourself in order to continue

About

Advertise

Reprints and Licensing

Resources